Skip to content
healthcare.dev

Topiramate

NDC 70518-2517, Topiramate, tablet, from REMEDYREPACK INC..

Product NDC
70518-2517
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076343
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2517 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE25 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
70518-2517-37051825170350 POUCH in 1 BOX (70518-2517-3) / 1 TABLET in 1 POUCH (70518-2517-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c90d81a9-a87b-48b0-8cf1-172b82e30127

Use it

Look up 70518-2517 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2517 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-2517. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.